Archive for 2014

  • aside

    First patient enrolled in Isofol Medical’s Phase I/II trial of Modufolin® in combination with 5‐FU and oxaliplatin in patients with stage IV colon cancer.

    Isofol Medical AB today announced that the first patient has been enrolled in a Phase I/II, single centre, open label…

    by
  • aside

    Recipharm forms new collaboration with Isofol Medical to exclusively manufacture Modufolin® and invests SEK 8 million in the company

    Recipharm and Isofol Medical AB, a Gothenburg-based pharmaceutical company developing novel products for unmet needs within oncology, are pleased to…

    by